Xingming Jiang

2.5k total citations
57 papers, 1.7k citations indexed

About

Xingming Jiang is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Xingming Jiang has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cancer Research, 48 papers in Molecular Biology and 34 papers in Surgery. Recurrent topics in Xingming Jiang's work include Cancer-related molecular mechanisms research (45 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (34 papers) and RNA modifications and cancer (27 papers). Xingming Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (45 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (34 papers) and RNA modifications and cancer (27 papers). Xingming Jiang collaborates with scholars based in China and Hong Kong. Xingming Jiang's co-authors include Yunfu Cui, Yi Xu, Kaiming Leng, Xiangyu Zhong, Zhenglong Li, Lining Huang, Sheng Tai, Zhidong Wang, Pengcheng Kang and Jinglin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Xingming Jiang

56 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingming Jiang China 23 1.5k 1.4k 468 137 85 57 1.7k
Weida Gong China 19 689 0.5× 918 0.7× 126 0.3× 146 1.1× 120 1.4× 50 1.1k
Wenwei Qian China 15 528 0.4× 752 0.5× 104 0.2× 158 1.2× 97 1.1× 30 978
Feng Qiu China 12 786 0.5× 754 0.5× 74 0.2× 69 0.5× 88 1.0× 17 938
Haibo Hu China 20 780 0.5× 855 0.6× 71 0.2× 75 0.5× 70 0.8× 28 1.0k
Guoqiang Qiu China 18 521 0.4× 785 0.6× 125 0.3× 199 1.5× 96 1.1× 56 1.1k
Zheng Xu China 20 301 0.2× 588 0.4× 142 0.3× 126 0.9× 110 1.3× 41 872
Jun Hao China 18 533 0.4× 735 0.5× 84 0.2× 192 1.4× 143 1.7× 38 1.0k
Marco De Martino Italy 20 405 0.3× 572 0.4× 151 0.3× 83 0.6× 114 1.3× 48 833
Keiichi Koshizuka Japan 24 920 0.6× 993 0.7× 61 0.1× 129 0.9× 106 1.2× 37 1.2k
Hongchun Wu China 18 465 0.3× 685 0.5× 107 0.2× 135 1.0× 37 0.4× 30 919

Countries citing papers authored by Xingming Jiang

Since Specialization
Citations

This map shows the geographic impact of Xingming Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingming Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingming Jiang more than expected).

Fields of papers citing papers by Xingming Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingming Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingming Jiang. The network helps show where Xingming Jiang may publish in the future.

Co-authorship network of co-authors of Xingming Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xingming Jiang. A scholar is included among the top collaborators of Xingming Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingming Jiang. Xingming Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Xinlei, et al.. (2025). A Novel 167‐Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination. Advanced Science. 12(10). e2409173–e2409173. 4 indexed citations
2.
3.
Ge, Yifei, et al.. (2024). Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma. Frontiers in Bioscience-Landmark. 29(1). 45–45. 3 indexed citations
4.
Zou, Xinlei, et al.. (2024). Forkhead box O1 in metabolic dysfunction-associated fatty liver disease: molecular mechanisms and drug research. Frontiers in Nutrition. 11. 1426780–1426780. 2 indexed citations
5.
Zou, Xinlei, et al.. (2024). Feedback loop LINC00511–YTHDF2–SOX2 regulatory network drives cholangiocarcinoma progression and stemness. SHILAP Revista de lepidopterología. 5(11). e743–e743. 3 indexed citations
6.
Gao, Xin, et al.. (2024). LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling. Cancer Gene Therapy. 31(4). 552–561. 8 indexed citations
7.
8.
Li, Jinglin, Xingming Jiang, Yi Xu, et al.. (2022). YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. International Journal of Biological Sciences. 18(11). 4301–4315. 16 indexed citations
9.
10.
Li, Xiang, et al.. (2020). LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis. Pathology - Research and Practice. 216(9). 153074–153074. 19 indexed citations
11.
Huang, Lining, Xingming Jiang, Zhenglong Li, et al.. (2020). Linc00473 potentiates cholangiocarcinoma progression by modulation of DDX5 expression via miR-506 regulation. Cancer Cell International. 20(1). 324–324. 11 indexed citations
12.
Wang, Weina, et al.. (2020). Knockdown of lncRNA SNHG20 Suppressed the Proliferation of Cholangiocarcinoma by Sponging miR-520f-3p. Cancer Biotherapy and Radiopharmaceuticals. 39(3). 178–187. 12 indexed citations
13.
Leng, Kaiming, Yi Xu, Pengcheng Kang, et al.. (2019). Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Cell Death and Disease. 10(4). 262–262. 31 indexed citations
14.
Li, Jinglin, Xingming Jiang, Zhenglong Li, et al.. (2018). Long noncoding RNA GHET1 in human cancer. Clinica Chimica Acta. 488. 111–115. 15 indexed citations
15.
Sun, Cheng, Lining Huang, Zhenglong Li, et al.. (2018). Long non-coding RNA MIAT in development and disease: a new player in an old game. Journal of Biomedical Science. 25(1). 23–23. 93 indexed citations
16.
Xu, Yi, Yue Yao, Wei Qin, et al.. (2018). Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition. Biomedicine & Pharmacotherapy. 99. 121–127. 25 indexed citations
17.
Huang, Lining, Xingming Jiang, Zhidong Wang, et al.. (2018). Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancers. Pathology - Research and Practice. 214(9). 1247–1252. 54 indexed citations
18.
Li, Jinglin, Zhenglong Li, Wangyang Zheng, et al.. (2017). PANDAR: a pivotal cancer-related long non-coding RNA in human cancers. Molecular BioSystems. 13(11). 2195–2201. 21 indexed citations
19.
Zhang, Fumin, Ming Wan, Yi Xu, et al.. (2017). Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/β-catenin-signaling pathway. Biomedicine & Pharmacotherapy. 94. 55–62. 63 indexed citations
20.
Zhou, Qingxin, Xingming Jiang, Zhidong Wang, Chunlong Li, & Yunfu Cui. (2015). Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis. Medical Oncology. 32(4). 105–105. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weida Gong Breakdown of academic impact, for papers by Wenwei Qian Breakdown of academic impact, for papers by Feng Qiu Breakdown of academic impact, for papers by Haibo Hu Breakdown of academic impact, for papers by Guoqiang Qiu Breakdown of academic impact, for papers by Zheng Xu Breakdown of academic impact, for papers by Jun Hao Breakdown of academic impact, for papers by Marco De Martino Breakdown of academic impact, for papers by Keiichi Koshizuka Breakdown of academic impact, for papers by Hongchun Wu
Rankless by CCL
2026